|
|
Active Org.- |
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with CTLA4 x CD28 x CSF-2R
100 Translational Medicine associated with CTLA4 x CD28 x CSF-2R
0 Patents (Medical) associated with CTLA4 x CD28 x CSF-2R